1

In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

No. 13-767V

Filed: August 8, 2016

* * * * * * * * * * * * * * * * UNPUBLISHED

RESHAMA SHAIKH, *

 * Special Master Gowen

Petitioner, *

 * Tetanus Diptheria acellularv. * Pertussis Vaccine; Chronic 

 * Inflammatory Demyelinating

SECRETARY OF HEALTH * Polyneuropathy.

AND HUMAN SERVICES, *

 *

Respondent. *

 *

* * * * * * * * * * * * * * * *

Lawrence R. Cohan, Anapol Weiss, Philadelphia, PA, for petitioner.

Darryl R. Wishard, United States Department of Justice, Washington, DC, for respondent.

DECISION ON JOINT STIPULATION1

On October 3, 2013, Reshama Shaikh (“petitioner”) filed a petition pursuant to the National 

Vaccine Injury Compensation Program.

2

42 U.S.C. §§ 300aa-1 to -34 (2012). Petitioner alleged 

that as a result of receiving a Tetanus Diptheria acellular-Pertussis (“Tdap”) vaccination on 

October 15, 2010, she suffered Chronic Inflammatory Demyelinating Polyneuropathy (“CIDP”). 

Stipulation ¶ 2, 4, filed Aug. 8, 2016. Further, petitioner alleged that she experienced residual 

effects of this injury for more than six months. Id. at ¶ 4. 

 

1 Because this decision contains a reasoned explanation for the undersigned’s action in this case, 

the undersigned intends to post this ruling on the website of the United States Court of Federal 

Claims, in accordance with the E-Government Act of 2002, 44 U.S.C. § 3501 note (2012) (Federal 

Management and Promotion of Electronic Government Services). As provided by Vaccine Rule 

18(b), each party has 14 days within which to request redaction “of any information furnished by 

that party: (1) that is a trade secret or commercial or financial in substance and is privileged or 

confidential; or (2) that includes medical files or similar files, the disclosure of which would 

constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b).

2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National 

Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 

42 U.S.C. §§ 300aa-1 to -34 (2012) (Vaccine Act or the Act). All citations in this decision to 

individual sections of the Vaccine Act are to 42 U.S.C.A. § 300aa.
2

On August 8, 2016, the parties filed a stipulation in which they state that a decision should 

be entered awarding compensation. Respondent denies that the Tdap vaccination caused or 

significantly aggravated petitioner’s alleged CIDP, or any other injury. Id. at ¶ 6. Respondent 

further denies that petitioner’s current disabilities are the result of a vaccine-related injiury. Id. 

Nevertheless, the parties agree to the joint stipulation, attached hereto as Appendix A. The 

undersigned finds the stipulation reasonable and adopts it as the decision of the Court in awarding 

damages, on the terms set forth therein.

The parties stipulate that petitioner shall receive the following compensation:

A lump sum of $500,000.00, in the form of a check payable to petitioner, Reshama 

Shaikh. This amount represents compensation for all damages that would be 

available under 42 U.S.C. § 300aa-15(a).

Id. at ¶ 8.

The undersigned approves the requested amount for petitioner’s compensation. 

Accordingly, an award should be made consistent with the stipulation. 

The clerk of the court SHALL ENTER JUDGMENT in accordance with the terms of 

the parties’ stipulation.3

IT IS SO ORDERED.

s/ Thomas L. Gowen

 Thomas L. Gowen

Special Master

 

3 Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of 

notice renouncing the right to seek review.